7-Bromo-5-(trifluoromethyl)-3,4-dihydronaphthalen-1(2H)-one, 95%, 100mg

[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl](methyl)amine hydrochloride, 95.0%, 1g

(2-aminobenzyl)dimethylamine hydrochloride, 95.0%, 5g

Ethanolamine hydrochloride, 99.0%, 500g

Dialysis membrane Spectra/Por® Biotech CE MWCO 100,000, 16 mm, 1 Piece(s)

2-Bromo-5-chloro-3-methylpyridine>98.0%(GC)5g

endo-BCN-PEG3-mal, 5mg

4,6-O-Ethylidene-alpha-D-glucopyranose>92.0%(GC)5g

METHYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHOXY)BENZOATE, 95.0%, 100mg

Fmoc-(S)-3-Amino-4-(2,4-dichloro-phenyl)-butyric acid, 97%, 1g

Ethyl 5-chloroimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 5g

tert-Butyl (3R)-3-(4-amino-3-fluorophenoxy)pyrrolidine-1-carboxylate, >95%, 1g

Potassium trifluoro(2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl)borate, 95.0%, 1g